Measurement of guanine nucleotide-binding protein activation by A1 adenosine receptor agonists in bovine brain membranes: stimulation of guanosine-5'-O-(3-[35S]thio)triphosphate binding

A Lorenzen, M Fuss, H Vogt and U Schwabe

Pharmakologisches Institut, Universitat Heidelberg, Germany.

Signal transduction by A1 adenosine receptors was investigated by measuring the modulation by adenosine agonists of guanosine-5'-O-(3- [35S]thio)triphosphate ([35S]GTP[S]) binding to guanine nucleotide- binding proteins (G proteins). The extent of stimulation of [35S]GTP[S] binding was dependent on the presence of high concentrations of Mg2+ (1- 10 mM), GDP (10 microM), and NaCl (100 mM). Under optimal conditions, the agonist (R)-N6-phenylisopropyladenosine [(R)-PIA] stimulated binding of [35S]GTP[S] to G proteins approximately 2.3-fold. All adenosine receptor agonists tested stimulated the binding of [35S]GTP[S] with a rank order of potency typical of A1 adenosine receptors in bovine tissues, (R)-PIA > 2-chloro-N6-cyclopentyladenosine > (S)-PIA > 5'-N-ethylcarboxamidoadenosine > 2-[4-(2- carboxyethyl)phenethylamino]-5'-N-ethylcarboxamidoadenosin e. The EC50 values for G protein activation correlated with the Ki value of agonists for inhibition of radioligand binding to the high affinity state of the A1 adenosine receptor. The inclusion of 100 mM NaCl as well as increasing GDP concentrations led to a parallel increase of Ki values and EC50 values. In addition, both compounds induced a shift of A1 adenosine receptors from the high affinity state for agonists to the low affinity state.

Volume 44, Issue 1, pp. 115-123, 07/01/1993
Copyright © 1993 by American Society for Pharmacology and Experimental Therapeutics

This article has been cited by other articles:

				K. A. O'Connor, L. J. Porrino, H. M. L. Davies, and S. R. Childers Time-Dependent Changes in Receptor/G-Protein Coupling in Rat Brain following Chronic Monoamine Transporter Blockade J. Pharmacol. Exp. Ther., May 1, 2005; 313(2): 510 - 517. [Abstract] [Full Text] [PDF]

				T. W. Vanderah, C. D. Schteingart, J. Trojnar, J.-L. Junien, J. Lai, and P. J.-M. Riviere FE200041 (D-Phe-D-Phe-D-Nle-D-Arg-NH2): A Peripheral Efficacious {kappa} Opioid Agonist with Unprecedented Selectivity J. Pharmacol. Exp. Ther., July 1, 2004; 310(1): 326 - 333. [Abstract] [Full Text] [PDF]

				M. Rousset, T. Cens, A. Gouin-Charnet, F. Scamps, and P. Charnet Ca2+ and Phosphatidylinositol 4,5-Bisphosphate Stabilize a G{beta}{gamma}-sensitive State of CaV2 Ca2+ Channels J. Biol. Chem., April 9, 2004; 279(15): 14619 - 14630. [Abstract] [Full Text] [PDF]

				A. Alt, I. J. McFadyen, C. D. Fan, J. H. Woods, and J. R. Traynor Stimulation of Guanosine-5'-O-(3-[35S]thio)triphosphate Binding in Digitonin-Permeabilized C6 Rat Glioma Cells: Evidence for an Organized Association of {micro}-Opioid Receptors and G Protein J. Pharmacol. Exp. Ther., July 1, 2001; 298(1): 116 - 121. [Abstract] [Full Text]

				M. A. Cox, C.-H. Jenh, W. Gonsiorek, J. Fine, S. K. Narula, P. J. Zavodny, and R. W. Hipkin Human Interferon-Inducible 10-kDa Protein and Human Interferon-Inducible T Cell {alpha} Chemoattractant Are Allotopic Ligands for Human CXCR3: Differential Binding to Receptor States Mol. Pharmacol., April 1, 2001; 59(4): 707 - 715. [Abstract] [Full Text]

				A. Lorenzen, C. Stannek, H. Lang, V. Andrianov, I. Kalvinsh, and U. Schwabe Characterization of a G Protein-Coupled Receptor for Nicotinic Acid Mol. Pharmacol., February 1, 2001; 59(2): 349 - 357. [Abstract] [Full Text]

				A. Newman-Tancredi, V. Audinot, C. Moreira, L. Verrièle, and M. J. Millan Inverse Agonism and Constitutive Activity as Functional Correlates of Serotonin h5-HT1B Receptor/G-Protein Stoichiometry Mol. Pharmacol., November 1, 2000; 58(5): 1042 - 1049. [Abstract] [Full Text]

				R. M. Quock, T. H. Burkey, E. Varga, Y. Hosohata, K. Hosohata, S. M. Cowell, C. A. Slate, F. J. Ehlert, W. R. Roeske, and H. I. Yamamura The delta -Opioid Receptor: Molecular Pharmacology, Signal Transduction, and the Determination of Drug Efficacy Pharmacol. Rev., September 1, 1999; 51(3): 503 - 532. [Abstract] [Full Text] [PDF]

				H. K. Happe, D. B. Bylund, and L. C. Murrin Alpha-2 Adrenergic Receptor Functional Coupling to G Proteins in Rat Brain During Postnatal Development J. Pharmacol. Exp. Ther., March 1, 1999; 288(3): 1134 - 1142. [Abstract] [Full Text]

				C. S. Breivogel, D. E. Selley, and S. R. Childers Cannabinoid Receptor Agonist Efficacy for Stimulating [35S]GTPgamma S Binding to Rat Cerebellar Membranes Correlates with Agonist-induced Decreases in GDP Affinity J. Biol. Chem., July 3, 1998; 273(27): 16865 - 16873. [Abstract] [Full Text] [PDF]

				A. Alt, A. Mansour, H. Akil, F. Medzihradsky, J. R. Traynor, and J. H. Woods Stimulation of Guanosine-5'-O-(3-[35S]Thio)Triphosphate Binding by Endogenous Opioids Acting at a Cloned Mu Receptor J. Pharmacol. Exp. Ther., July 1, 1998; 286(1): 282 - 288. [Abstract] [Full Text]

				R. Bosse, R. Garlick, B. Brown, and L. Menard Development of Nonseparation Binding and Functional Assays for G Protein-Coupled Receptors for High Throughput Screening: Pharmacological Characterization of the Immobilized CCR5 Receptor on FlashPlate(r) J Biomol Screen, June 1, 1998; 3(4): 285 - 292. [Abstract] [PDF]

				D. E. Selley, Q. Liu, and S. R. Childers Signal Transduction Correlates of Mu Opioid Agonist Intrinsic Efficacy: Receptor-Stimulated [35S]GTPgamma S Binding in mMOR-CHO Cells and Rat Thalamus J. Pharmacol. Exp. Ther., May 1, 1998; 285(2): 496 - 505. [Abstract] [Full Text]

				D. S. Gembitsky, S. Lovas, and R. F. Murphy Development of a High Throughput Functional Assay for Structure-Activity Studies of Neurokinin A Analogs J Biomol Screen, April 1, 1998; 3(3): 183 - 188. [Abstract] [PDF]

				A. C. Howlett, C. Song, B. A. Berglund, G. H. Wilken, and J. J. Pigg Characterization of CB1 Cannabinoid Receptors Using Receptor Peptide Fragments and Site-Directed Antibodies Mol. Pharmacol., March 1, 1998; 53(3): 504 - 510. [Abstract] [Full Text]

				P. G. Szekeres and J. R. Traynor Delta Opioid Modulation of the Binding of Guanosine-5'-O-(3-[35S]thio)triphosphate to NG108-15 Cell Membranes: Characterization of Agonist and Inverse Agonist Effects J. Pharmacol. Exp. Ther., December 1, 1997; 283(3): 1276 - 1284. [Abstract] [Full Text]

				C. Waeber and M. A. Moskowitz 5-Hydroxytryptamine1A and 5-Hydroxytryptamine1B Receptors Stimulate [35S]Guanosine-5'-O-(3-thio)triphosphate Binding to Rodent Brain Sections as Visualized by In Vitro Autoradiography Mol. Pharmacol., October 1, 1997; 52(4): 623 - 631. [Abstract] [Full Text]

				C. S. Breivogel, L. J. Sim, and S. R. Childers Regional Differences in Cannabinoid Receptor/G-protein Coupling in Rat Brain J. Pharmacol. Exp. Ther., September 1, 1997; 282(3): 1632 - 1642. [Abstract] [Full Text]

				J. Zhu, L.-Y. Luo, J.-G. Li, C. Chen, and L.-Y. Liu-Chen Activation of the Cloned Human Kappa Opioid Receptor by Agonists Enhances [35S]GTPgamma S Binding to Membranes: Determination of Potencies and Efficacies of Ligands J. Pharmacol. Exp. Ther., August 1, 1997; 282(2): 676 - 684. [Abstract] [Full Text]

				A. Newman-Tancredi, V. Audinot, C. Chaput, and L.V. a. M. J. Millan [35S]Guanosine-5'-O-(3-thio)triphosphate Binding as a Measure of Efficacy at Human Recombinant Dopamine D4.4 Receptors: Actions of Antiparkinsonian and Antipsychotic Agents J. Pharmacol. Exp. Ther., July 1, 1997; 282(1): 181 - 191. [Abstract] [Full Text]

				A. J. Williams, A. D. Michel, W. Feniuk, and P. P. A. Humphrey Somatostatin5 Receptor-Mediated [35S]Guanosine-5'-O-(3-thio)triphosphate Binding: Agonist Potencies and the Influence of Sodium Chloride on Intrinsic Activity Mol. Pharmacol., June 1, 1997; 51(6): 1060 - 1069. [Abstract] [Full Text]

				D. E. Selley, L. J. Sim, R. Xiao, Q. Liu, and S. R. Childers {micro}-Opioid Receptor-Stimulated Guanosine-5'-O-(gamma -thio)-triphosphate Binding in Rat Thalamus and Cultured Cell Lines: Signal Transduction Mechanisms Underlying Agonist Efficacy Mol. Pharmacol., January 1, 1997; 51(1): 87 - 96. [Abstract] [Full Text]